varenicline 0.03 MG per 0.05 mL (as varenicline tartrate 0.05 MG per 0.05 mL) Nasal Spray
- RxCUI
- 2572365
- RxNorm name
- varenicline 0.03 MG per 0.05 mL (as varenicline tartrate 0.05 MG per 0.05 mL) Nasal Spray
- Display name
- varenicline 0.03 MG per 0.05 mL (as varenicline tartrate 0.05 MG per 0.05 mL) Nasal Spray
- Full name
- varenicline 0.03 MG per 0.05 mL (as varenicline tartrate 0.05 MG per 0.05 mL) Nasal Spray
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:45
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 014c93dc-5737-479c-a9f0-aaadac1ac298 | varenicline 0.03 MG/ACTUAT Nasal Spray [PSN] · varenicline 0.03 MG/ACTUAT Nasal Spray [SCD] · varenicline 0.03 MG per 0.05 mL (as varenicline tartrate 0.05 MG per 0.05 mL) Nasal Spray [SY] | 3 | 14 | These highlights do not include all the information needed to use TYRVAYA safely and effectively. See full prescribing information for TYRVAYA. TYRVAYA ® (varenicline solution) nasal spray Initial U.S. Approval: 2006 | 20240212 |